Fawzy A. Saad

ORCID: 0000-0003-3170-3449
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Muscle Physiology and Disorders
  • RNA Research and Splicing
  • Knee injuries and reconstruction techniques
  • Silk-based biomaterials and applications
  • RNA modifications and cancer
  • Bone Metabolism and Diseases
  • CRISPR and Genetic Engineering
  • Bone health and treatments
  • Tendon Structure and Treatment
  • Cardiomyopathy and Myosin Studies
  • RNA regulation and disease
  • Angiogenesis and VEGF in Cancer
  • Bone and Dental Protein Studies
  • Bone health and osteoporosis research
  • Osteoarthritis Treatment and Mechanisms
  • Genomic variations and chromosomal abnormalities
  • Virus-based gene therapy research
  • Periodontal Regeneration and Treatments
  • Adipose Tissue and Metabolism
  • Phytase and its Applications
  • Galectins and Cancer Biology
  • Adipokines, Inflammation, and Metabolic Diseases
  • Ocular Oncology and Treatments
  • Genomics and Rare Diseases
  • Parkinson's Disease Mechanisms and Treatments

Gombe State University
2025

Harvard University
2004-2023

University of Padua
1992-2022

Boston Children's Hospital
2004-2019

Albert Einstein College of Medicine
2013-2016

West Virginia University
2013

Harvard University Press
2009

Université de Montréal
2006

Hôpital Notre-Dame
2006

University Health Network
2001

We report a novel technology for the rapid healing of large osseous and chondral defects, based upon genetic modification autologous skeletal muscle fat grafts.These tissues were selected because they not only possess mesenchymal progenitor cells scaffolding properties, but also can be biopsied, genetically modified returned to patient in single operative session.First generation adenovirus vector carrying cDNA encoding human bone morphogenetic protein-2 (Ad.BMP-2) was used gene transfer...

10.22203/ecm.v018a09 article EN European Cells and Materials 2009-12-31

Abstract Tissue engineering approaches that harness the stimulatory power of platelet‐rich plasma have produced encouraging results in anterior cruciate ligament (ACL) repair. However, a number recent studies demonstrated age‐dependent differences cellular responses to such an approach. Identifying reasons for these would allow counteracting them and consequently improve outcomes. In this study we hypothesized age‐related effects are caused by expression receptors growth factors released...

10.1002/jor.21111 article EN Journal of Orthopaedic Research® 2010-02-22
Fulya Akçimen Kimberly Paquette Peter Wild Crea Paula Saffie Awad Charles Achoru and 95 more Funmilola Taiwo Simon Ozomma Gerald Onwuegbuzie Marzieh Khani Spencer Grant Lukman Owolabi Chiamaka Okereke Olajumoke Oshinaike Emmanuel Iwuozo Paul Suhwan Lee Shyngle Oyakhire Nosakhare Osemwegie Kensuke Daida Sani Abubakar Adedunni Olusanya Mariam Isayan Rami Traurig Adebimpe I. Ogunmodede Sarah Samuel Mary B. Makarious Fawzy A. Saad Rashidat Amoke Olanigan Kristin Levine Ewere Marie Ogbimi Dan Vitale Francis Odiase Mathew J. Koretsky FI Ojini Olanike Odeniyi Zih‐Hua Fang Nkechi Obianozie Deborah J. Hall Ernest Nwazor Tao Xie Francisca Nwaokorie Mahesh Padmanaban Paul Nwani Ejaz A. Shamim Alero Nnama David G. Standaert Morenikeji Komolafe Marissa Dean Godwin Osaigbovo Elizabeth A. Disbrow Ismail O. Ishola Ashley Rawls Frank Imarhiagbe Shivika Chandra Cyril Erameh Vanessa K. Hinson Naomi Louie Ahmed O. Idowu Justin Solle Scott A. Norris Abdullahi Adinoyi Ibrahim Camilla Kilbane Gauthaman Sukumar Lisa Shulman Daniel Ezuduemoih Julia Staisch Sarah Breaux Clifton L. Dalgard Erin R. Foster Abiodun Bello Andrew Ameri Raquel Real Erica Ikwenu Huw R. Morris Roosevelt Anyanwu Erin Furr‐Stimming Kimberley Billingsley Wemimo Alaofin Pilar Álvarez Jerez Osigwe P. Agabi Dena Hernández Rufus Akinyemi Sampath Arepalli Laksh Malik Raymond Owolabi Yakub Nyandaiti Hampton L. Leonard Kolawole Wahab Kathryn Step Oladunni Abiodun Carlos Hernández Fatimah Binta Abdullahi Hirotaka Iwaki Soraya Bardien Christine Klein John Hardy Henry Houlden Kamalini Ghosh Galvelis Mike A. Nalls Nabila Dahodwala Whitley W. Aamodt

Abstract Elucidating the genetic contributions to Parkinson’s disease (PD) etiology across diverse ancestries is a critical priority for development of targeted therapies in global context. We conducted largest sequencing characterization potentially disease-causing, protein-altering and splicing mutations 710 cases 11,827 controls from genetically predicted African or admixed ancestries. explored copy number variants (CNVs) runs homozygosity (ROHs) prioritized early onset familial cases....

10.1101/2025.01.14.25320205 preprint EN cc-by medRxiv (Cold Spring Harbor Laboratory) 2025-01-15

Juvenile idiopathic arthritis (JIA) is the most common pediatric rheumatological condition. Although it has been proposed that JIA an autoimmune component, autoantigens are still unknown. Using biochemical and proteomic approaches, we identified molecular chaperone transthyretin (TTR) as antigenic target for B T cell immune responses. TTR was eluted from IgG complexes affinity purified 3 patients, a statistically significant increase in autoantibodies observed group of 43 patients. Three...

10.1172/jci.insight.85633 article EN JCI Insight 2016-02-24

Inadequate capillary growth in pressure-overload hypertrophy impairs myocardial perfusion and substrate delivery, contributing to progression failure.Capillary is tightly regulated by angiogenesis factors like vascular endothelial factor (VEGF) endogenous inhibitors such as the splice variant of VEGF receptor-1, sVEGFR-1.We hypothesized that inadequate expression up-regulation VEGFR-1 its soluble variant, sVEGFR-1, restrict hypertrophy. Methods resultsNeonatal New Zealand White rabbits...

10.1093/cvr/cvq321 article EN Cardiovascular Research 2010-10-08

Duchenne and Becker muscular dystrophies are allelic X-linked recessive neuromuscular diseases affecting both skeletal cardiac muscles. Therefore, owing to their single X chromosome, the affected boys receive pathogenic gene mutations from unknowing carrier mothers. Current pharmacological drugs palliative that address symptoms of disease rather than genetic cause imbedded in

10.2174/1566523223666221118160932 article EN Current Gene Therapy 2022-11-22

Alzheimer and Parkinson diseases are associated with cholinergic neuron loss deterioration of bone mineral density. Gene therapy through either gene transfer, CRISPR editing, or modulation holds the potential to cure diseases. The emerging role weight-bearing exercise in prevention of, care for, osteoporosis, obesity, diabetes has been previously recognized. Moreover, endurance offers a viable alternative reduce amyloid peptides deposits while increasing density patients. β-amyloid peptides,...

10.2174/1566523223666230419101023 article EN Current Gene Therapy 2023-05-03

Abstract Osteopontin is a noncollagenous, phosphorylated extracellular glycoprotein, expressed in mineralized and nonmineralized tissues, organs body fluids. The protein contains an RGD tripeptide cell‐binding motif, subjected to variety of posttranslational modifications that play important roles its multiple biological functions, such as bone remodeling inhibition pathological calcification. In this study, we have bovine osteopontin prokaryotic system identified the seven amino acid...

10.1002/jcb.21453 article EN Journal of Cellular Biochemistry 2007-07-05

The incidence rates of Duchenne and Becker muscular dystrophies (X-linked recessive) in a given sample the Italian population were recalculated using results DNA dystrophin analysis. While rate dystrophy remained unchanged, new figure for (7.2 per 100,000 male live births) was much higher than previously reported, since molecular diagnosis revealed additional cryptic cases, but this is still an underestimate.

10.1159/000110334 article EN Neuroepidemiology 1993-01-01

In human, germ line mutations in the tumor suppressor retinoblastoma (Rb) predispose individuals to retinoblastoma, whereas somatic inactivation of Rb contributes progression a large spectrum cancers. mice, is highly expressed restricted cell lineages including neurogenic, myogenic, and hematopoietic systems, disruption gene leads specific embryonic defects these tissues. The symmetry between expression mutant mice suggest that transcriptional control during embryogenesis pivotal for normal...

10.1074/jbc.m005474200 article EN cc-by Journal of Biological Chemistry 2001-01-01
Coming Soon ...